The Use of Novel Drugs Can Effectively Improve Response, Delay Relapse and Enhance Overall Survival in Multiple Myeloma Patients with Renal Impairment

BACKGROUND: Renal impairment is a common feature in multiple myeloma and is considered a poor prognostic factor. AIM: To determine the impact of novel drugs (i.e. bortezomib, lenalidomide and thalidomide) in the treatment of myeloma patients with renal impairment. The primary endpoint was overall su...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Uttervall, Katarina, Duru, Adil D., Lund, Johan, Liwing, Johan, Gahrton, Gösta, Holmberg, Erik, Aschan, Johan, Alici, Evren, Nahi, Hareth
Format: Artigo
Sprog:Inglês
Udgivet: Public Library of Science 2014
Fag:
Research Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4086950/
https://ncbi.nlm.nih.gov/pubmed/25003848
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0101819
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker